A recent cross-sectional study of patients with CD-associated perianal fistulas treated with ADA revealed a significant association between high serum ADA levels and clinical remission of fistulas.34 A number of questions and concerns remain to be addressed with regard to therapeutic drug monitoring of biological therapy in IBD. This evidence concerns the gene ADA and inflammatory bowel disease.